Emergent BioSolutions Inc.
- EBS
- NYSE
- Drug Manufacturers - Specialty & Generic
- Biodefense/Medical Countermeasures
- Vaccines/Therapeutics
$6.38
Today −11.14%Quote Oct 16, 2026, 08:00 PM UTC
−9.12%over the last month
Max drawdown −11.9%From 1-month high −11.9%3 months −17.0%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$327.1M
Quote Oct 16
Next earnings
Nov 2
Expected, not confirmed
Analyst target
$10.00
+56.7% from here
Floor
$6.22
2.6% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about EBSPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
Q2 2026 revenue $234.3M
- Product$226.8M96.8%
- Contracts and Grants$7.5M3.2%
Industry
Drug Manufacturers - Specialty & Generic
Employees
900
Founded
1998